11
12, 2012

Emerick Completes RTO of European-Focused Gold Exploration Company

11 Dec, 2012

VANCOUVER, Dec. 11, 2012 /CNW/ – Emerick Resources Corp. (TSX-V: ERC.H) (“Emerick” or the “Company”) is pleased to announce that it has completed its reverse takeover (“RTO”) of Medgold Resource Ltd. (“Medgold”), a private European-focused gold exploration company. Subject to TSX Venture Exchange acceptance, the Company’s shares will trade under the name, Medgold Resources Corp. The newly merged company will explore for major gold deposits in the Mediterranean region, focusing on countries with a known history of gold production, and mining-friendly legal/fiscal codes. The Company’s project portfolio includes gold projects[…]

06
11, 2012

Emerick provides update on proposed acquisition of Western European properties

06 Nov, 2012

VANCOUVER, Nov. 6, 2012 /CNW/ – Emerick Resources Corp. (TSX-V: ERC) is pleased to announce that it has signed a binding Share Purchase Agreement to acquire all of the outstanding shares of Medgold Resource Ltd. (“Medgold”), a private company incorporated in England and Wales focused on the exploration and development of precious and base metals in Western Europe. (See Emerick news release of May 8, 2012.) To acquire Medgold, the Company will issue 32,287,500 shares in its capital stock to Medgold’s shareholders in proportion to their respective shareholdings in Medgold.[…]

08
05, 2012

Emerick to Acquire Western European Properties and Apply to Graduate to Tier 2 of TSXV

08 May, 2012

VANCOUVER, May 8, 2012 /CNW/ – Emerick Resources Corp. (TSXV: ERC) (“Emerick” or the “Company”) is pleased to announce that it has entered into a non-binding letter agreement dated April 26, 2012 to acquire all of the outstanding shares of Medgold Resource Ltd. (“Medgold”) (the “Transaction”), a private company incorporated in England and Wales focused on the exploration and development of precious and base metals in Western Europe. The Proposed Transaction To acquire Medgold, the Company will issue 32,287,500 shares in its capital stock to Medgold’s shareholders in proportion to[…]